Free Trial
→ Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX (From InvestorPlace) (Ad)tc pixel Free ELVN Stock Alerts

Enliven Therapeutics (ELVN) Short Interest Ratio & Short Volume

Enliven Therapeutics logo
$40.75 +0.46 (+1.14%)
Closing price 04:00 PM Eastern
Extended Trading
$41.52 +0.77 (+1.90%)
As of 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Enliven Therapeutics Short Interest Overview

As of April 15, 2026, Enliven Therapeutics (ELVN) had a short interest of 5.37 million shares sold short, representing 11.91% of the public float. This marks a -11.22% decrease in short interest since the prior report. The short interest ratio (days to cover) is 4.3, meaning it would take 4.3 days of the average trading volume of 742,574 shares to cover all short positions.

Current Short Interest
5,374,014 shares
Previous Short Interest
6,053,456 shares
Change Vs. Previous Month
-11.22%
Dollar Volume Sold Short
$236.19 million
Short Interest Ratio
4.3 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
60,900,000 shares
Short Percent of Float
11.91%
Today's Trading Volume
606,389 shares
Average Trading Volume
742,574 shares
Today's Volume Vs. Average
82%
Short Selling Enliven Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Enliven Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ELVN Short Interest Over Time

ELVN Days to Cover Over Time

ELVN Percentage of Float Shorted Over Time

Enliven Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20265,374,014 shares $236.19 million -11.2%11.9%4.28 $43.95
3/31/20266,053,456 shares $237.30 million -26.3%13.7%2.86 $39.20
3/13/20268,215,500 shares $228.14 million +3.0%18.5%10.54 $27.77
2/27/20267,979,674 shares $236.92 million -1.2%18.0%12.26 $29.69
2/13/20268,078,549 shares $215.86 million +2.7%18.4%11.21 $26.72
1/30/20267,870,182 shares $208.17 million -14.1%17.9%7.89 $26.45
1/15/20269,166,736 shares $230.73 million +10.3%20.8%4.19 $25.17
12/31/20258,312,949 shares $128.02 million +2.5%18.9%11.85 $15.40
12/15/20258,111,262 shares $139.27 million +1.4%18.4%9.81 $17.17
11/28/20257,996,827 shares $172.73 million +2.6%18.2%14.74 $21.60
11/14/20257,794,126 shares $172.02 million +0.2%17.7%10.37 $22.07
10/31/20257,782,638 shares $182.27 million +21.2%17.7%18.19 $23.42
10/15/20256,420,000 shares $139.51 million +12.6%15.3%13.6 $21.73
9/30/20255,700,000 shares $116.68 million +17.3%13.6%12.2 $20.47
9/15/20254,860,000 shares $89.91 million -0.6%11.6%9.6 $18.50
8/31/20254,890,000 shares $99.12 million -1.0%12.8%9.6 $20.27
8/15/20254,940,000 shares $99.89 million -2.8%13.0%9.7 $20.22
7/31/20255,080,000 shares $95.55 million -8.3%12.9%10 $18.81
7/15/20255,540,000 shares $119.94 million -9.6%14.3%11.3 $21.65
6/30/20256,130,000 shares $122.97 million -7.4%15.8%12.8 $20.06
6/15/20256,620,000 shares $145.04 million +1.9%17.1%15.1 $21.91
5/31/20256,500,000 shares $115.96 million -0.6%20.2%19 $17.84
5/15/20256,540,000 shares $116.54 million -6.0%20.3%21.7 $17.82
4/30/20256,960,000 shares $131.82 million -6.5%21.8%25.5 $18.94
4/15/20257,440,000 shares $126.85 million +2.3%23.5%28.1 $17.05
3/31/20257,270,000 shares $143.07 million -1.0%22.9%27.4 $19.68
3/15/20257,340,000 shares $152.23 million -0.5%23.2%31.7 $20.74
2/28/20257,380,000 shares $153.73 million -0.8%23.4%33.2 $20.83
2/15/20257,440,000 shares $161.30 million +4.6%23.6%34.8 $21.68
1/31/20257,110,000 shares $155.42 million +0.1%23.1%31.7 $21.86
1/15/20257,100,000 shares $160.89 million +2.5%23.0%31.2 $22.66
12/31/20246,930,000 shares $155.93 million +0.9%22.5%31.7 $22.50
12/15/20246,870,000 shares $159.04 million -0.6%22.3%27 $23.15
11/30/20246,910,000 shares $168.47 million -2.3%22.9%27.3 $24.38
11/15/20247,070,000 shares $172.58 million +2.3%23.4%27.8 $24.41
10/31/20246,910,000 shares $192.44 million +6.1%23.8%29.2 $27.85
10/15/20246,510,000 shares $181.11 million +6.7%22.5%27.1 $27.82
9/30/20246,100,000 shares $155.79 million +10.3%21.1%25.2 $25.54
9/15/20245,530,000 shares $123.43 million +3.4%19.1%22.3 $22.32
8/31/20245,350,000 shares $117.06 million +0.6%18.6%21.4 $21.88
8/15/20245,320,000 shares $126.46 million +0.4%18.5%20.5 $23.77
7/31/20245,300,000 shares $139.81 million +1.0%19.6%17.3 $26.38
7/15/20245,250,000 shares $131.78 million -10.4%19.4%16.3 $25.10
6/30/20245,860,000 shares $136.95 million +5.6%21.7%14.7 $23.37
6/15/20245,550,000 shares $120.44 million +2.0%20.6%15.4 $21.70
5/31/20245,440,000 shares $122.78 million +2.6%20.3%15.4 $22.57
5/15/20245,300,000 shares $127.20 million +12.1%19.8%16.1 $24.00
4/30/20244,730,000 shares $82.25 million +1.9%18.6%16 $17.39
4/15/20244,640,000 shares $92.52 million +9.7%18.3%18.7 $19.94
3/31/20244,230,000 shares $74.41 million -2.3%19.8%28.5 $17.59
3/15/20244,330,000 shares $51.83 million No Change20.4%30.6 $11.97
2/29/20244,330,000 shares $69.15 million -11.8%20.5%29.2 $15.97
2/15/20244,910,000 shares $84.94 million -4.8%23.3%31.8 $17.30
1/31/20245,160,000 shares $81.01 million +0.2%26.3%36.3 $15.70
1/15/20245,150,000 shares $63.35 million -6.5%26.9%39.2 $12.30
12/31/20235,510,000 shares $76.26 million +3.8%28.8%44.9 $13.84
12/15/20235,310,000 shares $63.19 million +1.3%27.3%41.1 $11.90
11/30/20235,240,000 shares $59.00 million +0.4%27.0%54.9 $11.26
11/15/20235,220,000 shares $57.16 million +1.0%26.9%59.3 $10.95
10/31/20235,170,000 shares $64.06 million +1.4%23.5%53.6 $12.39
10/15/20235,100,000 shares $62.48 million -0.6%23.2%51.6 $12.25
9/30/20235,130,000 shares $70.08 million -0.8%23.3%49.8 $13.66
9/15/20235,170,000 shares $83.24 million +1.0%23.7%44.7 $16.10
8/31/20235,120,000 shares $79.97 million -3.4%23.5%26.3 $15.62
8/15/20235,300,000 shares $87.29 million -1.1%24.8%24.2 $16.47
7/31/20235,360,000 shares $101.52 million -1.1%26.1%25.2 $18.94
7/15/20235,420,000 shares $97.99 million +1.3%26.4%24.8 $18.08
6/30/20235,350,000 shares $109.19 million +39.7%26.1%23.4 $20.41
6/15/20233,830,000 shares $74.34 million +29.4%18.7%16.8 $19.41
5/31/20232,960,000 shares $54.17 million +9.2%14.4%21 $18.30
5/15/20232,710,000 shares $53.74 million No Change13.2%22.1 $19.83

ELVN Short Interest - Frequently Asked Questions

Short interest is the volume of Enliven Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 5,374,014 shares of ELVN short. 11.91% of Enliven Therapeutics' shares are currently sold short. Learn More on Enliven Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELVN shares currently have a short interest ratio of 4.3. Learn More on Enliven Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Enliven Therapeutics: Jane Street Group LLC, Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.91% of Enliven Therapeutics' floating shares are currently sold short.

Enliven Therapeutics saw a decrease in short interest in April. As of April 15th, there was short interest totaling 5,374,014 shares, a decrease of 11.2% from the previous total of 6,053,456 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

11.91% of Enliven Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enliven Therapeutics: Arrowhead Pharmaceuticals, Inc. (8.90%), Axsome Therapeutics, Inc. (6.74%), Praxis Precision Medicines, Inc. (13.95%), Abivax SA Sponsored ADR (3.23%), Vaxcyte, Inc. (10.29%), Nuvalent, Inc. (6.50%), Krystal Biotech, Inc. (11.39%), Cytokinetics, Incorporated (12.35%), ImmunityBio, Inc. (44.72%), Qiagen N.V. (3.10%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

Short selling ELVN is an investing strategy that aims to generate trading profit from Enliven Therapeutics as its price is falling. ELVN shares are trading up $0.88 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enliven Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELVN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELVN, twice per month. The most recent reporting period available is April, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ELVN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ELVN) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
The Death of the Nasdaq?
The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...
Chaikin Analytics | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Nobody's Asking Where The SpaceX Money Comes From
When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...
Americas Gold Company | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel